France Affirms Inquiry on Defected Breast Implants

France guarantees investigation to identify flawed French-made breast implants at the centre of a health scare, when a supplier confirmed selling non-standard silicone to their manufacturer.

A growing litany of accusations against now-defunct Poly Implant Prothese (PIP) has triggered a worldwide scare with several countries, including France, advising thousands of women to have its implants removed.

Early Physiotherapy of the Arm After Breast Cancer Surgery Reduces Lymphedema
Clinical trial recommends that early physio can reduce deblitating complication such as lymphedema of the arm after radiotherapy or surgery lymphedema.

Between 300,000 and 400,000 women in 65 countries from Europe to Latin America are believed to have implants made with sub-standard gel PIP used to cut its costs.

"All the elements now suggest that the gel (used in PIP's implants) was truly contaminated," French Health Minister Xavier Bertrand told France 2 television.

"How was this not detected by checks?" he asked. "I want to know everything... I have asked for investigations at the Directorate General of Health and (health safety agency) AFSSAPS to know what happened, how these checks were done."

Breast Cancer Prevention in Postmenopausal Women With Exemestane
An international study establishes the positive role of exemestane in reducing breast cancer risk in postmenopausal women.

Bertrand also said that he would in the next few days be contacting his counterparts around Europe to discuss the scandal.

Based in the south of France, PIP was shut down and its products banned in 2010 after it was revealed to have been using industrial-grade silicone gel that caused abnormally high rupture rates.

France Denies Cancer Risk, But Recommends Removal of Breast Implants
France's health ministry has denied reports of cancer risk from breast implants made by local firm, but has recommended women with the implants to have them removed.

Fears over its implants spread globally last month after French health authorities advised 30,000 women to have their PIP implants removed because of the increased risk of rupture.

Officials have also said that cancer, including 16 cases of breast cancer, has been detected in 20 French women with the implants but have insisted there is no proven link with the disease.

Brit Authorities Investigate Factual Scale of Faulty Breast Implants
The British government is charging an urgent review of defective silicone breast implants rendered to over 40,000 women.

Prosecutors in Marseille, near PIP's laboratory at Seyne-sur-Mer on the Mediterranean, have received more than 2,500 complaints from French women who received the implants and are pursuing a criminal investigation. Italian prosecutors have also announced a criminal probe.

The firm's 72-year-old founder, Jean-Claude Mas, has admitted to using non-standard silicone gel in the implants but denied any health risks.

A French supplier of PIP on Tuesday confirmed selling silicone to the firm that was meant only for industrial uses.

"All the specifications of the product that was ordered from us corresponded to industrial material," Pierre Gaches, the CEO of Toulouse-based Gaches Chimie, told AFP.

He said the company had supplied PIP with industrial-grade silicone since the early 2000s but that PIP "never gave us any information on how it planned to use" the material.

On Monday France's RTL radio revealed that an exact breakdown of the materials used in the implants showed that they also contained additives used in the oil and rubber industries.

Britain at the weekend ordered an urgent review into the risks to 42,000 British women given the implants, after the country's biggest cosmetic surgery chain revealed that rupture rates were seven times higher than previously thought.

Authorities in other countries have advised women to consult their doctors over the implants. Some nations, including Bolivia and Venezuela, have said that in some cases the implants will be removed for free.

France is also paying to have the implants removed among French women, at an estimated cost of up to 60 million euros ($78 million), and has said it will pursue PIP in the courts for damages.

Source-AFP